Cover Image

Structure-activity relationship studies on the macrolide exotoxin mycolactone of Mycobacterium ulcerans.

BACKGROUND: Mycolactones are a family of polyketide-derived macrolide exotoxins produced by Mycobacterium ulcerans, the causative agent of the chronic necrotizing skin disease Buruli ulcer. The toxin is synthesized by polyketide synthases encoded by the virulence plasmid pMUM. The apoptotic, necroti...

Full description

Saved in:

Bibliographic Details
Main Authors:	Nicole Scherr (Author), Philipp Gersbach (Author), Jean-Pierre Dangy (Author), Claudio Bomio (Author), Jun Li (Author), Karl-Heinz Altmann (Author), Gerd Pluschke (Author)
Format:	Book
Published:	Public Library of Science (PLoS), 2013-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Antibody-Mediated Neutralization of the Exotoxin Mycolactone, the Main Virulence Factor Produced by Mycobacterium ulcerans.
by: Jean-Pierre Dangy, et al.
Published: (2016)

Development of an ELISA for the quantification of mycolactone, the cytotoxic macrolide toxin of Mycobacterium ulcerans.
by: Louisa Warryn, et al.
Published: (2020)

Regulation of mycolactone, the Mycobacterium ulcerans toxin, depends on nutrient source.
by: Caroline Deshayes, et al.
Published: (2013)

Detection of Mycolactone A/B in Mycobacterium ulcerans-Infected Human Tissue.
by: Fred Stephen Sarfo, et al.
Published: (2010)

Molecular Mechanisms Underpinning the Circulation and Cellular Uptake of Mycobacterium ulcerans Toxin Mycolactone
by: Bruno Tello Rubio, et al.
Published: (2021)

Improved protective efficacy of a species-specific DNA vaccine encoding mycolyl-transferase Ag85A from Mycobacterium ulcerans by homologous protein boosting.
by: Audrey Tanghe, et al.
Published: (2008)

Mycobacterium ulcerans and other mycolactone-producing mycobacteria should be considered a single species.
by: Sacha J Pidot, et al.
Published: (2010)

Identification of the Mycobacterium ulcerans protein MUL_3720 as a promising target for the development of a diagnostic test for Buruli ulcer.
by: Anita Dreyer, et al.
Published: (2015)

Proteomic analysis of the action of the Mycobacterium ulcerans toxin mycolactone: targeting host cells cytoskeleton and collagen.
by: José B Gama, et al.
Published: (2014)

Differential gene repertoire in Mycobacterium ulcerans identifies candidate genes for patho-adaptation.
by: Michael Käser, et al.
Published: (2008)

Accelerated detection of mycolactone production and response to antibiotic treatment in a mouse model of Mycobacterium ulcerans disease.
by: Paul J Converse, et al.
Published: (2014)

Simple, Rapid Mycobacterium ulcerans Disease Diagnosis from Clinical Samples by Fluorescence of Mycolactone on Thin Layer Chromatography.
by: Anita Wadagni, et al.
Published: (2015)

Mycolactone diffuses from Mycobacterium ulcerans-infected tissues and targets mononuclear cells in peripheral blood and lymphoid organs.
by: Hui Hong, et al.
Published: (2008)

Mycolactone gene expression is controlled by strong SigA-like promoters with utility in studies of Mycobacterium ulcerans and buruli ulcer.
by: Nicholas J Tobias, et al.
Published: (2009)

Analysis of the vaccine potential of plasmid DNA encoding nine mycolactone polyketide synthase domains in Mycobacterium ulcerans infected mice.
by: Virginie Roupie, et al.
Published: (2014)

Use of Recombinant Virus Replicon Particles for Vaccination against Mycobacterium ulcerans Disease.
by: Miriam Bolz, et al.
Published: (2015)

Correction: Mycolactone Gene Expression Is Controlled by Strong SigA-Like Promoters with Utility in Studies of Mycobacterium ulcerans and Buruli Ulcer
Published: (2010)

Local Cellular Immune Responses and Pathogenesis of Buruli Ulcer Lesions in the Experimental Mycobacterium Ulcerans Pig Infection Model.
by: Miriam Bolz, et al.
Published: (2016)

Development of a temperature-switch PCR-based SNP typing method for Mycobacterium ulcerans.
by: Katharina Röltgen, et al.
Published: (2012)

A Sero-epidemiological Approach to Explore Transmission of Mycobacterium ulcerans.
by: Kobina Assan Ampah, et al.
Published: (2016)

Interferon-γ Is a Crucial Activator of Early Host Immune Defense against Mycobacterium ulcerans Infection in Mice.
by: Raphael Bieri, et al.
Published: (2016)

Spatial Distribution of Mycobacterium ulcerans in Buruli Ulcer Lesions: Implications for Laboratory Diagnosis.
by: Marie-Thérèse Ruf, et al.
Published: (2016)

The cell surface protein MUL_3720 confers binding of the skin pathogen Mycobacterium ulcerans to sulfated glycans and keratin.
by: Christopher J Day, et al.
Published: (2021)

Mycobacterium ulcerans disease
by: Tjip S. van der Werf, et al.

Sero-epidemiology as a tool to screen populations for exposure to Mycobacterium ulcerans.
by: Dorothy Yeboah-Manu, et al.
Published: (2012)

Experimental infection of the pig with Mycobacterium ulcerans: a novel model for studying the pathogenesis of Buruli ulcer disease.
by: Miriam Bolz, et al.
Published: (2014)

Serological evaluation of Mycobacterium ulcerans antigens identified by comparative genomics.
by: Sacha J Pidot, et al.
Published: (2010)

Introduction of Mycobacterium ulcerans disease in the Bankim Health District of Cameroon follows damming of the Mapé River.
by: Koen Vandelannoote, et al.
Published: (2020)

Mycobacterium ulcerans persistence at a village water source of Buruli ulcer patients.
by: Martin W Bratschi, et al.
Published: (2014)

Locally Confined Clonal Complexes of Mycobacterium ulcerans in Two Buruli Ulcer Endemic Regions of Cameroon.
by: Miriam Bolz, et al.
Published: (2015)

Spatiotemporal Co-existence of Two Mycobacterium ulcerans Clonal Complexes in the Offin River Valley of Ghana.
by: Araceli Lamelas, et al.
Published: (2016)

First cultivation and characterization of Mycobacterium ulcerans from the environment.
by: Françoise Portaels, et al.
Published: (2008)

Mycobacterium ulcerans Disease with Unusual Sites Not to Be Ignored
by: Sangaré Abdoulaye, et al.
Published: (2014)

In-vitro activity of avermectins against Mycobacterium ulcerans.
by: Till F Omansen, et al.
Published: (2015)

In vitro activity of SPR719 against Mycobacterium ulcerans, Mycobacterium marinum and Mycobacterium chimaera.
by: Sacha J Pidot, et al.
Published: (2021)

Vaccination with the Surface Proteins MUL_2232 and MUL_3720 of Mycobacterium ulcerans Induces Antibodies but Fails to Provide Protection against Buruli Ulcer.
by: Miriam Bolz, et al.
Published: (2016)

Chronic wounds in Sierra Leone: Searching for Buruli ulcer, a NTD caused by Mycobacterium ulcerans, at Masanga Hospital.
by: Helen R Please, et al.
Published: (2021)

Single nucleotide polymorphism typing of Mycobacterium ulcerans reveals focal transmission of buruli ulcer in a highly endemic region of Ghana.
by: Katharina Röltgen, et al.
Published: (2010)

The incubation period of Buruli ulcer (Mycobacterium ulcerans infection).
by: Jason A Trubiano, et al.
Published: (2013)

Spontaneous healing of Mycobacterium ulcerans disease in Australian patients.
by: Daniel P O'Brien, et al.
Published: (2019)